Shingles vaccine linked to lower risk of heart-related deaths

A recent breakthrough in medical research suggests that the shingles vaccine, primarily known for preventing a painful skin rash, may offer a surprising bonus: protection for your heart.

Studies involving over one million adults have linked the vaccine to a significant decrease in cardiovascular risks.

One major 2026 study found that for patients already living with heart disease, vaccination was associated with a 46% lower risk of major cardiac events.

Experts believe the vaccine works by preventing the systemic inflammation that a shingles infection typically triggers.

This inflammation can damage blood vessels and increase the risk of blood clots, which are common causes of heart attacks.

Because this protection is significant, some cardiologists are now proposing that vaccines should be considered a 'fourth pillar' of heart disease prevention, alongside managing blood pressure, cholesterol, and diabetes.

As health agencies continue to study the long-term effects of modern vaccines like Shingrix, this research highlights that the shingles shot is not just for skin health; it may be a vital tool for protecting your heart for years to come.